SKYEPHARMA INC has a total of 72 patent applications. Its first patent ever was published in 1992. It filed its patents most often in United States, Australia and Israel. Its main competitors in its focus markets pharmaceuticals, machines and packaging and shipping are NOSTRUM PHARMACEUTICALS INC, EDELSTAM INC and EMERAMED LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Australia | 8 | |
#3 | Israel | 8 | |
#4 | New Zealand | 8 | |
#5 | Canada | 7 | |
#6 | EPO (European Patent Office) | 7 | |
#7 | Japan | 7 | |
#8 | Norway | 4 | |
#9 | Finland | 3 | |
#10 | Hong Kong | 3 | |
#11 | WIPO (World Intellectual Property Organization) | 3 | |
#12 | Bulgaria | 1 | |
#13 | Republic of Korea | 1 | |
#14 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Packaging and shipping | |
#4 | Biotechnology | |
#5 | Micro-structure and nano-technology |
# | Name | Total Patents |
---|---|---|
#1 | Kim Sinil | 21 |
#2 | Ye Qiang | 19 |
#3 | Sankaram Mantripragada | 14 |
#4 | Sankaram Mantripragada Bhima | 12 |
#5 | Kim Taehee | 10 |
#6 | Katre Nandini | 9 |
#7 | Murdande Sharad B | 6 |
#8 | Sankaram Mantripragada B | 5 |
#9 | Gruber Andras | 5 |
#10 | Thrift Richard N | 4 |
Publication | Filing date | Title |
---|---|---|
CA2375371A1 | Oil-core compositions for the sustained release of hydrophobic drugs | |
US6277413B1 | Biodegradable compositions for the controlled release of encapsulated substances | |
HK1013259A1 | Vesicles with controlled release of actives | |
AU9494298A | Sustained-release liposomal anesthetic compositions | |
CA2564120A1 | Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes | |
US6106858A | Modulation of drug loading in multivescular liposomes | |
US5997899A | Method for producing liposomes with increased percent of compound encapsulated | |
US5993850A | Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances | |
EP0695169A1 | Multivesicular cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use |